Pieris Pharmaceuticals, Inc.

PIRS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$83,602$17,396$38,635$117,764
Short-Term Investments$0$8,970$20,534$0
Receivables$358$572$5,810$3,313
Inventory$0$0$0$0
Other Curr. Assets$4,274$11,742$8,445$6,548
Total Curr. Assets$88,234$38,680$73,424$127,625
Property Plant & Equip (Net)$0$0$20,697$23,031
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$1,369$2,904
Total NC Assets$0$0$22,066$25,935
Other Assets$0$0$0$0
Total Assets$88,234$38,680$95,490$153,560
Liabilities
Payables$4,586$3,372$4,154$8,609
Short-Term Debt$0$0$859$1,049
Tax Payable$0$0$0$0
Deferred Revenue$0$0$20,824$25,116
Other Curr. Liab.$7,452$8,550$10,746$15,787
Total Curr. Liab.$12,038$11,922$36,583$50,561
LT Debt$0$0$12,244$13,841
Deferred Rev, NC$0$0$18,734$38,403
Deferred Tax Liab, NC$0$0-$18,734-$38,403
Other NC Liab.$13,589$0$18,734$38,403
Total NC Liab.$13,589$0$30,978$52,244
Other Liabilities$0$0$0$0
Cap. Leases$0$0$13,103$14,890
Total Liabilities$25,627$11,922$67,561$102,805
Equity
Pref Stock$88,234$0$0$0
Common Stock$11$98$74$72
Retained Earnings-$93,735-$314,964-$290,421-$257,144
AOCI$3$28-$254$829
Other Equity$0$341,596$318,530$306,998
Total Equity$62,607$26,758$27,929$50,755
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$88,234$38,680$95,490$153,560
Net Debt-$83,602-$17,396-$25,532-$102,874